Use of a B-cell-depleting antibody for treatment of polyoma virus infections

US7718425B2 · kind B2 · utility

Assignee

• Charité-Universit{umlaut over ( )}ätsmedizin Berlin · DE

Inventors

• Petra Reinke · Berlin, DE
• Hans-Dieter Volk · Berlin, DE
• Markus Hammer · Neu-Ulm, DE
• Nina Babel · Berlin, DE
• Gana Bold · Berlin, DE

Key dates

• Filing date: May 2, 2007
• Grant date: May 18, 2010
• Expiry date: May 2, 2027

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07K2317/24
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to uses of a B-cell-depleting antibody for the treatment of a polyoma virus infection.